Filing Details
- Accession Number:
- 0001209191-23-005746
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-31 17:14:39
- Reporting Period:
- 2023-01-27
- Accepted Time:
- 2023-01-31 17:14:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1422143 | Kura Oncology Inc. | KURA | Pharmaceutical Preparations (2834) | 611547851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1910331 | James Thomas Doyle | C/O Kura Oncology, Inc. 12730 High Bluff Drive, Suite 400 San Diego CA 92130 | Svp, Finance & Accounting | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-01-27 | 682 | $13.89 | 17,707 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-27 | 866 | $13.89 | 16,841 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 500 | Indirect | spouse's 401(k) |
Footnotes
- Sell-to cover for taxes associated with the vesting of RSUs received by the Reporting Person dated 1/26/22.
- Includes 1,806 shares acquired on May 17, 2022 and 1,583 shares acquired on November 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.
- Sell-to cover for taxes associated with the vesting of RSUs received by the Reporting Person dated 2/7/22.
Billionaire Hedge Funds
